Country
|
Sera analysed
|
Chagas patients (%)
|
ELISA 1 positive
|
ELISA 2 negative
|
WB positive
|
RT-PCR negative
|
Negative control
|
---|
Argentina | 122 | 40 | 41 | 50 | 36 | 50 | 12 |
Bolivia | 117 | 68 | 11 | - | - | - | 20 |
Brazil | 50 | 100 | 0 | - | - | - | 22 |
Cuba | 10 | 0* | 0 | - | - | - | 5 |
Mexico | 100 | 70 | 9 | - | - | - | 8 |
Portugal | 11 | 100#
| 0 | - | - | - | 8 |
Total |
410
|
63
|
61
|
50
|
36
|
50
|
81
|
- Column 1 identifies the country of origin for the samples; results of the TrV sera analyses. Numbers in columns 4–7 indicate the number of serum samples employed in each analysis. ELISA assay 1 corresponds to reactivity against structural proteins, and ELISA assay 2 corresponds to reactivity against the non-structural protein RdRp. WB refers to immunoblotting analysis against the structural proteins of TrV. RT-PCR refers to reverse transcriptase-PCR*. Cuba is a non-endemic country for Chagas disease. #The sera from Portugal are imported case of Chagas disease, mainly from Brazil.